Locked Out of a Cure? Only a Fraction of Early Alzheimer’s Patients Eligible for New Drugs Post author:Randy Banks Post published:October 8, 2023 Post category:News Only a small fraction of older adults with early Alzheimer’s symptoms are eligible for new monoclonal antibody treatments, according to a recent study. Full Story You Might Also Like 800,000 Australians will live with dementia by 2058. This is how we can prepare August 28, 2023 The battle to boost our deep sleep – and help stop dementia March 13, 2023 Japan prepares national project to deal with dementia October 8, 2023
Only a small fraction of older adults with early Alzheimer’s symptoms are eligible for new monoclonal antibody treatments, according to a recent study. Full Story
